Longeva editorial policy

Editorial responsibility sits with the founder, Oleksandr Bortnik. We no longer use the "Peptide Expert" pseudonym.

If an outside author or reviewer with a real name and credentials ever joins, they get their own author page, no anonymous "experts."

• Peer-reviewed articles, cited with a DOI or a stable link.
• Preclinical work, phase 1–3 trials, and an approved drug are attributed differently. Numbers from clinical trials are not carried over onto an RUO vial as "effect."
• Forum reviews are never cited as evidence.

• We do not invent a human dose when the literature has none.
• We do not promise anti-aging, weight loss, or a cure.
• We do not sell an Rx brand disguised as a research sample.
• We do not put star ratings on a product until a real review program exists.

Found an error in a monograph, a COA, or a dose from a paper? Email [email protected]. The page keeps its last-modified date.

Longeva sells the compounds it writes about. That is always true, which is why commercial copy keeps the RUO frame and links to primary sources instead of "our own experience using it."